{
  "report_rows": [
    {
      "kpi": "Non-GAAP EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.28 vs. cons ~$1.25",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.42B vs. cons ~$3.40B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$289M vs. cons ~$282M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 non-GAAP EPS guide",
      "prediction": "BETTER",
      "answer": "guide ~$5.28-5.40 (narrow to high end) vs. cons ~$5.31 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 net sales growth guide",
      "prediction": "UNCHANGED",
      "answer": "guide ~+3-5% vs. cons ~+4.5% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Value-creation savings run-rate",
      "prediction": "UNCHANGED",
      "answer": "guide ~$125M run-rate by YE2026 vs. cons ~$125M (2H26-weighted, >$200M target)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Adjusted EBITDA growth guide",
      "prediction": "UNCHANGED",
      "answer": "guide ~mid-single-digit growth off ~$1.1B vs. cons ~+5-6% (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.0,
  "day5_path": "FADE",
  "day5_rationale": "Stock is up ~+18% into the print and sits near 52-week highs, so a modest EPS/EBITDA beat on an easy year-ago comp is largely discounted; guidance is more likely a narrow-to-high-end than a clean raise, and savings are back-half weighted so out-period EPS estimates get nudged only marginally. Combined with the fresh, unquantified management reorg (potential new restructuring charges) and JV-remeasurement/buyback-flattered EPS quality questions, the setup skews to a sell-the-news fade with limited positive revision fuel.",
  "day5_confidence": "LOW"
}